biOasis AGM re-scheduled for September 21, 2017
|
|
BIOASIS TECHNOLOGIES INC
|
Jul 28, 2017 11:17AM
|
Re: BETonMACE ClinicalTrial.gov updated
|
|
Resverlogix Corp.
|
Sep 29, 2017 08:07PM
|
Technical Difficulties?
|
|
Resverlogix Corp.
|
Oct 10, 2017 04:55PM
|
biOasis Appoints Catherine London, Executive Vice President, Head of Corporate Communications and Investor Relations
|
|
BIOASIS TECHNOLOGIES INC
|
Jun 26, 2017 10:33AM
|
Re: Huge profit taking today on the "pinks"
|
|
BIOASIS TECHNOLOGIES INC
|
Sep 20, 2017 04:04PM
|
Re: Resverlogix Announces Annual and Special Meeting of Shareholders
|
|
Resverlogix Corp.
|
Oct 06, 2016 11:23PM
|
Re: An invitation to join the conversation here on Agoracom
|
|
BIOASIS TECHNOLOGIES INC
|
Jun 22, 2018 03:54PM
|
Re: Answer from IR - 250 confrimed MACE would require disclosure
|
|
Resverlogix Corp.
|
Jan 31, 2019 12:06PM
|
Re: European Atherosclerosis Society Congress May 29 - June 1
|
|
Resverlogix Corp.
|
May 30, 2016 07:35PM
|
Re: 2019 Potential Events
|
|
Resverlogix Corp.
|
May 22, 2019 09:05PM
|
biOasis Announces Non-Brokered Private Placement
|
|
BIOASIS TECHNOLOGIES INC
|
Mar 21, 2017 09:56PM
|
Re: Presentation
|
|
Zenith Epigenetics
|
Nov 03, 2017 10:58AM
|
Happy New Year from biOasis Technology inc.
|
|
BIOASIS TECHNOLOGIES INC
|
Dec 22, 2016 09:58AM
|
Re: BETonMACE top line data
|
|
Resverlogix Corp.
|
Jan 16, 2018 05:13PM
|
Re: What I learned
|
|
Resverlogix Corp.
|
Jun 17, 2020 09:53PM
|
Re: DDF Summit: Drug Delivery & Formulation, August 28-29, 2017
|
|
BIOASIS TECHNOLOGIES INC
|
Aug 01, 2017 11:05AM
|
Re: Bear
|
|
Resverlogix Corp.
|
Mar 28, 2020 11:44AM
|
Re: DDF Summit: Drug Delivery & Formulation, August 28-29, 2017
|
|
BIOASIS TECHNOLOGIES INC
|
Aug 09, 2017 10:24PM
|
Licensing The Transcend Platform – A New Era in Neuroscience
|
|
BIOASIS TECHNOLOGIES INC
|
Apr 18, 2016 10:37PM
|
Re: To those still complaining about flagging violations and removing posts.....
|
|
Resverlogix Corp.
|
Jun 23, 2016 06:24PM
|